Cancer Research Archives
Mar. 2, 2018—Vanderbilt (VU + VUMC, collaboratively) anticipates the opportunity to choose one nominee for the V Foundation 2018 Translational Research Award.
Apr. 20, 2017—A study led by Vanderbilt-Ingram Cancer Center (VICC) investigators suggests a drug combination which includes a PDK1 protein blocker may be more effective for breast cancer that has become resistant to cyclin-dependent kinase (CDK4/6) targeted therapy.
Nov. 13, 2015—Vanderbilt University may nominate one candidate for the Mary Kay Foundation Translational Cancer Research Grant program for 2016.
Feb. 12, 2015—The V Scholar Award supports young tenure-track faculty to begin their cancer research career.
Feb. 12, 2015—Vanderbilt may nominate one candidate for the V Foundation 2015 Translational Grant.